EXTH-65. USING METHYLATION PROFILES TO GUIDE THE REPURPOSING OF CHEMOTHERAPIES AGAINST HIGH-RISK MENINGIOMAS

Meningioma is the most common primary brain tumor with nearly thirty thousand new cases in the US every year. While most meningiomas grow slowly, hence categorized as benign, they can still impact brain structures and result in disability or lethality. Currently, there is no widely accepted chemothe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Tran, Anh, Scholtens, Denise, Zhang, Lyndsee, Pokorny, Jenny, Baran, Aneta, Sahm, Felix, Aldape, Kenneth, James, Charles, Horbinski, Craig
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Preclinical Experimental Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651328/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.419
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki